Effect of Nigella sativa on acne vulgaris
Phase 3
- Conditions
- Acne Vulgaris.Acne vulgaris
- Registration Number
- IRCT20180712040449N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Patients between 14–35 years old from both genders
Patients with mild to moderate acne as defined by the Investigator’s Global Assessment (IGA) scale
Enrolled female participants should have a negative pregnancy test
Exclusion Criteria
Any aesthetic facial procedure including laser therapy and tissue/dermal injectables within the last 6 months
Patients having wound and infection on face
Patients with any skin disorders that might interfere with the diagnosis or evaluation of acne
Very severe acne vulgaris
Pregnancy or breastfeeding
Patients with any uncontrolled systemic disease
Using oral isotretinoin in the last 6 months
History of hypersensitivity to blackseed
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method People with mild to moderate acne vulgaris. Timepoint: Acne lesions counting at baseline, days 14, 30, and 60. Method of measurement: Investigator’s global assessment grading for acne vulgaris.
- Secondary Outcome Measures
Name Time Method